What we do

HistologiX Ltd is the UK’s leading independent laboratory providing quantitative Immunohistochemistry (IHC) and In Situ Hybridisation - RNAscope (ISH) screening services.

Accredited to GLP/GCP Histologix is a Contract Research Organisation (CRO) providing expert services to the Pharmaceutical and Biotechnology industry in quantitative Biomarker target validation/distribution, quantitative efficacy, proof of Concept/Mechanism, Tissue Cross-Reactivity screening, Companion Diagnostic testing, Histology, Histopathology Analysis (Medical and Veterinary), Digital Pathology, Image Analysis and Human tissue sourcing. 

Whether screening animal or human tissues, over-expressing cell lines, xenografts, clinical patient biopsies, or undertaking histopathology in medical or toxicity studies Histologix has the expertise to offer solutions to many of your research and regulatory issues.

Our Directors, researchers and technical staff have in excess of 100 years of experience within this niche area and our aim is to develop and provide reproducible quality screening services at reasonable prices.


Antibodies intended for therapeutic clinical use must undergo screening in human tissue as part of any regulatory preclinical safety assessment.

Find out more

News & resources